Wockhardt

57
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
2,183.10
-3.5 (-0.16%)
BSENSE

Nov 20

BSE+NSE Vol: 9.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Wockhardt Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
238.00
-16.00
-420.00
-624.00
-411.00
916.00
Adjustment
455.00
455.00
677.00
635.00
554.00
-943.00
Changes In working Capital
-282.00
-492.00
-8.00
153.00
367.00
-143.00
Cash Flow after changes in Working Capital
411.00
-53.00
249.00
164.00
510.00
-170.00
Cash Flow from Operating Activities
390.00
-22.00
219.00
153.00
413.00
-287.00
Cash Flow from Investing Activities
-231.00
-780.00
-138.00
-118.00
-204.00
1,471.00
Cash Flow from Financing Activities
-54.00
409.00
334.00
-315.00
-71.00
-1,171.00
Net Cash Inflow / Outflow
105.00
-393.00
415.00
-280.00
138.00
13.00
Opening Cash & Cash Equivalents
112.00
505.00
90.00
370.00
232.00
219.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
217.00
112.00
505.00
90.00
370.00
232.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wockhardt
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
238
466.19
-228.00
-48.95%
Adjustment
455
155.66
300.00
192.30%
Changes In working Capital
-282
-73.8
-209.00
-282.11%
Cash Flow after changes in Working Capital
411
548.06
-137.00
-25.01%
Cash Flow from Operating Activities
390
509.13
-119.00
-23.40%
Cash Flow from Investing Activities
-231
-394.59
163.00
41.46%
Cash Flow from Financing Activities
-54
-123.68
69.00
56.34%
Net Cash Inflow / Outflow
105
-9.14
114.00
1248.80%
Opening Cash & Cash Equivalents
112
91.05
21.00
23.01%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
217
81.91
136.00
164.92%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 1,872.73% vs -110.05% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
390.00
-22.00
1,872.73%